Search all trials

Find therapies in clinical trials near you – page 40

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study on Atezolizumab for Patients with High-Risk Diffuse Large B-Cell Lymphoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Study on the Safety and Effectiveness of 19CP02 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of 19CP02 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:19Cp02

Contact Research Centre

Hepatitis D

Not recruiting

Registered drugNo placebo

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Bulevirtide

Contact Research Centre

Obesity+1

Not recruiting

Registered drugNo placebo

Study Comparing Tirzepatide and Semaglutide for Weight Loss in Adults with Obesity or Overweight and Related Health Issues

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ly3298176

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of BCMACP03 for Patients with Relapsed or Refractory Multiple Myeloma

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Bcmacp03

Contact Research Centre

Urea cycle disorder+3

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Hhalpc

Contact Research Centre

Systemic mastocytosis

Not recruiting

Investigational

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide

Contact Research Centre

Colon cancer metastatic

Not recruiting

Registered drugNo placebo

Study on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Balstilimab

Contact Research Centre

Colon cancer stage III+1

Not recruiting

Registered drug

Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Anti-glomerular basement membrane disease

Not recruiting

Registered drugNo placebo

Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Multiple sclerosis+4

Not recruiting

Registered drug

Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Dimethyl Fumarate

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Find therapies in clinical trials near you – page 40

507 trials match your criteria

Diffuse large B-cell lymphoma

Study on Atezolizumab for Patients with High-Risk Diffuse Large B-Cell Lymphoma

Study on the Safety and Effectiveness of 19CP02 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Study on the Safety and Effectiveness of 19CP02 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Hepatitis D

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Obesity+1

Study Comparing Tirzepatide and Semaglutide for Weight Loss in Adults with Obesity or Overweight and Related Health Issues

Plasma cell myeloma refractory

Study on the Safety and Effectiveness of BCMACP03 for Patients with Relapsed or Refractory Multiple Myeloma

Urea cycle disorder+3

Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

Systemic mastocytosis

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Colon cancer metastatic

Study on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer

Colon cancer stage III+1

Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

Anti-glomerular basement membrane disease

Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

Multiple sclerosis+4

Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

Breast cancer

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.